Physicians Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $335K | Buy |
13,923
+4
| +0% | +$105 | 0.08% | 91 |
|
|
2026
Q1 | $391K | Buy |
13,919
+344
| +3% | +$9.16K | 0.11% | 83 |
|
|
2025
Q4 | $338K | Sell |
13,575
-307
| -2% | -$7.74K | 0.09% | 90 |
|
|
2025
Q3 | $354K | Sell |
13,882
-1,063
| -7% | -$26.2K | 0.1% | 89 |
|
|
2025
Q2 | $362K | Sell |
14,945
-6,682
| -31% | -$156K | 0.11% | 89 |
|
|
2025
Q1 | $548K | Sell |
21,627
-7,632
| -26% | -$200K | 0.17% | 78 |
|
|
2024
Q4 | $776K | Sell |
29,259
-4,437
| -13% | -$120K | 0.24% | 65 |
|
|
2024
Q3 | $975K | Sell |
33,696
-5,293
| -14% | -$154K | 0.3% | 60 |
|
|
2024
Q2 | $1.09M | Sell |
38,989
-4,009
| -9% | -$110K | 0.35% | 56 |
|
|
2024
Q1 | $1.19M | Sell |
42,998
-1,020
| -2% | -$28.3K | 0.42% | 55 |
|
|
2023
Q4 | $1.27M | Sell |
44,018
-6,780
| -13% | -$205K | 0.48% | 52 |
|
|
2023
Q3 | $1.69M | Sell |
50,798
-620
| -1% | -$21.9K | 0.69% | 37 |
|
|
2023
Q2 | $1.89M | Sell |
51,418
-250
| -0.5% | -$9.73K | 0.74% | 35 |
|
|
2023
Q1 | $2.11M | Buy |
51,668
+50
| +0.1% | +$2.16K | 0.89% | 33 |
|
|
2022
Q4 | $2.65M | Sell |
51,618
-810
| -2% | -$38.8K | 1.19% | 23 |
|
|
2022
Q3 | $2.29M | Sell |
52,428
-929
| -2% | -$45.1K | 1.11% | 25 |
|
|
2022
Q2 | $2.8M | Buy |
53,357
+1,079
| +2% | +$55K | 1.25% | 23 |
|
|
2022
Q1 | $2.71M | Sell |
52,278
-350
| -0.7% | -$18.2K | 1.03% | 31 |
|
|
2021
Q4 | $3.11M | Buy |
52,628
+900
| +2% | +$44.6K | 1.15% | 29 |
|
|
2021
Q3 | $2.23M | Buy |
51,728
+10,420
| +25% | +$462K | 0.9% | 36 |
|
|
2021
Q2 | $1.62M | Buy |
41,308
+11,465
| +38% | +$446K | 0.66% | 46 |
|
|
2021
Q1 | $1.08M | Buy |
29,843
+1,315
| +5% | +$46.7K | 0.46% | 57 |
|
|
2020
Q4 | $1.05M | Sell |
28,528
-2,244
| -7% | -$82.3K | 0.51% | 56 |
|
|
2020
Q3 | $1.07M | Buy |
30,772
+215
| +0.7% | +$7.54K | 0.53% | 51 |
|
|
2020
Q2 | $948K | Buy |
30,557
+3
| +0% | +$102 | 0.52% | 53 |
|
|
2020
Q1 | $946K | Buy |
30,554
+3,375
| +12% | +$115K | 0.65% | 45 |
|
|
2019
Q4 | $1.01M | Sell |
27,179
-389
| -1% | -$13.9K | 0.55% | 54 |
|
|
2019
Q3 | $940K | Sell |
27,568
-104
| -0.4% | -$3.78K | 0.54% | 53 |
|
|
2019
Q2 | $1.14M | Sell |
27,672
-1,002
| -3% | -$39.8K | 0.67% | 44 |
|
|
2019
Q1 | $1.16M | Buy |
28,674
+711
| +3% | +$28.5K | 0.72% | 41 |
|
|
2018
Q4 | $1.16M | Buy |
27,963
+8,535
| +44% | +$354K | 0.84% | 37 |
|
|
2018
Q3 | $813K | Sell |
19,428
-106
| -0.5% | -$4.08K | 0.56% | 56 |
|
|
2018
Q2 | $672K | Sell |
19,534
-843
| -4% | -$28.8K | 0.5% | 61 |
|
|
2018
Q1 | $682K | Sell |
20,377
-6,113
| -23% | -$210K | 0.54% | 61 |
|
|
2017
Q4 | $910K | Sell |
26,490
-211
| -0.8% | -$7.2K | 0.69% | 45 |
|
|
2017
Q3 | $904K | Sell |
26,701
-211
| -0.8% | -$6.78K | 0.74% | 45 |
|
|
2017
Q2 | $858K | Sell |
26,912
-1,660
| -6% | -$52.4K | 0.73% | 45 |
|
|
2017
Q1 | $927K | Sell |
28,572
-1,129
| -4% | -$35.6K | 0.8% | 42 |
|
|
2016
Q4 | $1.04M | Buy |
29,701
+287
| +1% | +$8.76K | 0.85% | 39 |
|
|
2016
Q3 | $945K | Buy |
29,414
+952
| +3% | +$31.8K | 0.79% | 41 |
|
|
2016
Q2 | $951K | Buy |
28,462
+48
| +0.2% | +$1.53K | 0.83% | 38 |
|
|
2016
Q1 | $799K | Sell |
28,414
-295
| -1% | -$8.43K | 0.72% | 43 |
|
|
2015
Q4 | $879K | Buy |
+28,709
| New | +$903K | 0.81% | 41 |
|
Other funds holding PFE
Physicians Financial Services's PFE Position: Q2 2026 in Review
Physicians Financial Services increased its Pfizer (PFE) stake by 0.03% in Q2 2026, buying an estimated $105 and bringing the position to 13,923 shares worth $335K. The position accounts for 0.08% of the portfolio, ranked #91.
Physicians Financial Services first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $3.11M in Q4 2021. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Physicians Financial Services held 13,923 shares of Pfizer worth $335K as of Q2 2026.
- Physicians Financial Services bought 4 Pfizer shares in Q2 2026, an estimated $105.
- Pfizer made up 0.08% of Physicians Financial Services's portfolio in Q2 2026, its #91 holding.
- Physicians Financial Services first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
- Physicians Financial Services's Pfizer position peaked at $3.11M in Q4 2021.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Physicians Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.